TD-1473 for Active Ulcerative Colitis (UC)

Trial Details

  • 40 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Study drug TD-1473 or placebo


This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TD-1473 in subjects with moderately-to-severely active UC over 28 days. This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and clinical, endoscopic, and histologic assessments.

Full Trial Details